Which insulin resistance indices best predict future frailty progression in a cardiovascular-kidney-metabolic syndrome stage 0–3 population: a national prospective cohort and machine learning study

Ruikang Liu,Guangyi Yang,Yiying Liu,Jun Li,Botan Xu,Guancheng Ye,Xuanchun Huang,Shiyi Tao,Tiantian Xue,Yonghao Li,Fuyuan Zhang

Published 2025 in Diabetology & Metabolic Syndrome

ABSTRACT

Insulin resistance (IR) is implicated in frailty progression within Cardiovascular-Kidney-Metabolic (CKM) syndrome populations. While multiple non-insulin-based IR indices have been proposed, their comparative utility in predicting frailty across early CKM stages (0–3) remains unclear. Identifying reliable, non-insulin-based IR indices for predicting frailty index (FI) across early CKM stages (0–3) remains challenging. This prospective cohort study analyzed 4,354 adults (≥ 45 years) from the China Health and Retirement Longitudinal Study (2011–2015). We evaluated and compared 12 IR indices for predicting frailty progression. Associations were assessed using multivariable logistic regression. Machine learning (RFE, Boruta, and LASSO) identified optimal predictors, and a Random Forest (RF) model incorporating key covariates was developed and validated. After full adjustment, CTI (OR = 1.19), TyG-WHtR (OR = 1.12), TyG-WC (OR = 1.00), and eGDR (OR = 0.87) significantly predicted FI (all p < 0.05). Among all indices, TyG-WHtR demonstrated the most stable discriminative performance across CKM stages 0–3 (AUCs: 0.52–0.59, all p < 0.001). Machine learning consistently selected TyG-WHtR as the top predictor. The final 13-variable RF model achieved an AUC of 0.74. SHAP analysis confirmed TyG-WHtR, age, depressive symptoms, and renal biomarkers as key predictors. TyG-WHtR is a robust, stable predictor of frailty progression in individuals with CKM syndrome stages 0–3. Its integration into clinical practice, potentially via the developed web tool, could enhance early frailty risk stratification.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-40 of 40 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1